MENU
RNLXD
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION

Renalytix (RNLXD) Ownership - Who owns Renalytix?

Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease... Show more

Details

Group
Domestic Stock Funds
Category
Health Services
Capitalization
36.67M
P/E Ratio
N/A
Total Cash
4.68M
Projected Growth
N/A
Total Debt
8.21M
Revenue
3M
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.54
Total Debt/Equity
N/A
Revenue/Share
0.55 USD as % of share price

Fundamentals

RNLXD
Capitalization
36.7M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
4.68M
Total Cash/Share
0.54
Total Debt
8.21M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.55%
Revenue
3M
ROE
N/A
Book Value
-1.37M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-3.5
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1.06M
Current Ratio
2.43
Current Revenue Per Employee
15510.64
Dividends Per Share - Security
N/A
EBITDA
-21.3M
Float
N/A
Float - Current
N/A
Gross Income Margin
54.60
Revenue To Assets
-289.94
Shares Held By Institutions
N/A
Shares Outstanding - Current
8.74M
Total Liabilities
12.8M
Total Volume MTD
N/A
Value
N/A
Gain YTD
13.536
View a ticker or compare two or three
RNLXD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

Industry ServicestotheHealthIndustry

Profile
Fundamentals
Details